Cargando…
Discovery of Small Molecule KCC2 Potentiators Which Attenuate In Vitro Seizure-Like Activity in Cultured Neurons
KCC2 is a K(+)-Cl(−) cotransporter that is expressed in neurons throughout the central nervous system. Deficits in KCC2 activity have been implicated in a variety of neurological disorders, including epilepsy, chronic pain, autism spectrum disorders, and Rett syndrome. Therefore, it has been hypothe...
Autores principales: | Prael III, Francis J., Kim, Kwangho, Du, Yu, Spitznagel, Brittany D., Sulikowski, Gary A., Delpire, Eric, Weaver, C. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263442/ https://www.ncbi.nlm.nih.gov/pubmed/35813195 http://dx.doi.org/10.3389/fcell.2022.912812 |
Ejemplares similares
-
KCC3a, a Strong Candidate Pathway for K(+) Loss in Alkalemia
por: Ferdaus, Mohammed Zubaerul, et al.
Publicado: (2022) -
Loss of KCC2 in GABAergic Neurons Causes Seizures and an Imbalance of Cortical Interneurons
por: Zavalin, Kirill, et al.
Publicado: (2022) -
KCC2 downregulation facilitates epileptic seizures
por: Chen, Lulan, et al.
Publicado: (2017) -
A role for KCC3 in maintaining cell volume of peripheral nerve fibers
por: Flores, Bianca, et al.
Publicado: (2018) -
A Trafficking-Deficient Mutant of KCC3 Reveals Dominant-Negative Effects on K–Cl Cotransport Function
por: Ding, Jinlong, et al.
Publicado: (2013)